Pfizer Stock Performance
as on September 24, 2026 at 2:15 pm IST
Day's Low
Day's High
$27.85$28.23
1.17%
Downside
0.18%
Upside
52 Week's Low
52 Week's High
$23.58$29.2116.32%
Downside
3.66%
Upside
Pfizer share price movements today
- Previous Close
- $27.93
- Open
- $27.91
- Volume
- 28.1M
- Market Cap
- $158.1B
- Dividend Yield
- 6.16%
- Day's Low - High
- $27.85 - $28.23
- 52 Week Low - High
- $23.58 - $29.21
Pfizer Historical Returns
- 1 Month Return
- + 0.75 %
- 3 Month Return
- + 17.22 %
- 1 Year Return
- + 16.98 %
- 3 Year Return
- -13.8 %
- 5 Year Return
- -35.87 %
Pfizer Stock Fundamentals & Key Indicators
Check Pfizer market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$158.1B
EPS (TTM)
0.7568
Dividend Yield
6.16%
Quarterly Earnings Growth YOY
-0.10%
PE Ratio (TTM)
36.91
Industry PE ratio
9.58
PEG Ratio
-0.6172671612191061
EBITDA
12.6B
Revenue (TTM)
63.7B
Profit Margin
71.32%
Return On Equity TTM
4.89%
Pfizer Stock Valuation
Track how Pfizer P/E has moved over time to understand its valuation trends.
Pfizer in the last 5 years
Lowest (9.16x)
December 31, 2022
Industry (9.58x)
December 31, 2025
Today (18.31x)
December 31, 2025
Highest (76.17x)
December 31, 2023
Today’s Price to Earnings Ratio: 18.31x
Pfizer vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Pfizer with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $158.1B | -35.87% | 36.91 | 71.32% | 6.16% | |
| StrongBuy | $649.4B | 63.78% | 31.12 | 67.91% | 1.96% | |
| Buy | $339.3B | 2.68% | 21.96 | 50.18% | 2.89% |
Stock Returns calculator for Pfizer Stock including INR - Dollar returns
The Pfizer stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Pfizer investment value today
Current value as on today
₹1,26,109
Returns
₹26,109
(+26.11%)
Returns from Pfizer Stock
₹16,978 (+16.98%)
Dollar Impact
₹9,131 (+9.13%)
Analyst Recommendation on Pfizer Stock
Based on 19 analysts
36.84%
Buy
63.16%
Hold
0.00%
Sell
Based on 19 analysts, 63.1578947368421% of analysts recommend a 'BUY' rating for Pfizer. Average target price of $28.88
Pfizer Share Price Target
Get share price movements and forecasts by analysts on Pfizer.
What analysts predicted
2.42%UPSIDE
Target Price
$28.88
Current Price
$28.18
Analyzed by
19 Analysts
Target
$28.88
Pfizer target price $28.88, a slight upside of 2.42% compared to current price of $28.18. According to 19 analysts rating.
Indian Investors' Interest in Pfizer Stock
Investment in Pfizer Shares on INDmoney has dropped by -6.15% in the last 30 days, indicating reduced investment activity.
Time period: to
Search interest for Pfizer Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Pfizer Quarterly Profit & Loss
All numbers in Millions USD
Pfizer Annual Profit & Loss
All numbers in Millions USD
Pfizer Quarterly Cash Flow
All numbers in Millions USD
Pfizer Annual Cash Flow
All numbers in Millions USD
Pfizer News & Key Events
Today's Timeline - 23 September
Wed, 02:50 PM
-Pfizer's strong free cash flow supports continued dividend payments, totaling $9.8 billion over the past year.
Wed, 04:44 PM
-Pfizer's revenue primarily from Global Biopharmaceuticals, leveraging AI in drug research and development.
Wed, 08:09 PM
-Pfizer's international business revenue grew significantly, with new products generating $4 billion, indicating strong growth potential.
Today's Timeline - 23 September
Wed, 09:02 PM
-Pfizer's Q1 2026 revenue rose 5.4%, driven by newer assets, despite significant declines in COVID product sales.
Wed, 10:07 PM
-Pfizer's revenue guidance raised by $500 million, driven by strong non-COVID sales despite declining COVID product revenue.
Insights on Pfizer
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Pfizer Inc. has shown positive revenue growth over the last two quarters. Revenue increased from $14.45 billion to $15.03 billion, representing an average growth of 3.9% per quarter.
- POSITIVE IMPACT
Price Rise
In the last 3 months, PFE stock has moved up by 17.2%
NO EFFECTAgainst Peers
In the last 3 years, Johnson & Johnson has given 67.7% return, outperforming this stock by 81.5%
- NO EFFECT
Against Peers
In the last 1 year, Johnson & Johnson has given 52.3% return, outperforming this stock by 35.3%
NEGATIVE IMPACTProfit Down
Pfizer Inc. has seen a significant decline in its net profit for the last two quarters. The profit fell from $2.68 billion to a loss of $246 million, which represents an average decrease of 109.2% per quarter.
About Pfizer
| Organisation | Pfizer |
| Headquarters | 66 Hudson Boulevard East, New York City, NY, 10001-2192, US |
| Industry | Drug Manufacturers - General |
| CEO | Albert Bourla |
| E-voting on shares | Click here to vote |
Key Management of Pfizer
Name | Title |
|---|---|
Mr. Dennis P. Hancock | Executive VP & Chief Information Officer |
Ms. Francesca M. DeMartino | Chief Investor Relations Officer |
Ms. Cecile Guegan | Interim CFO & Executive VP |
Dr. Chris Boshoff FMedSci, M.D., Ph.D. | Chief Scientific Officer and President of Research & Development |
Mr. Douglas M. Lankler | Executive VP & Chief Legal Officer |
Mr. Aamir Malik | Executive VP & Chief U.S. Commercial Officer |
Ms. Jennifer B. Damico | Senior VP, Controller & Principal Accounting Officer |
Ms. Payal Sahni Becher | Chief People Experience Officer & Executive VP |
Dr. Michael S. Vincent M.D., Ph.D. | Senior VP and Chief Scientific Officer of Inflammation & Immunology |
Dr. Albert Bourla D.V.M., Ph.D. | Chairman of the Board & CEO |
FAQs
What is Pfizer share price today?
Pfizer share price today is $28.18 as on at the close of the market. Pfizer share today touched a day high of $28.23 and a low of $27.85.
What is the 52 week high and 52 week low for Pfizer share?
Pfizer share touched a 52 week high of $29.21 on and a 52 week low of $23.58 on . Pfizer stock price today i.e. is closed at $28.18,which is 3.53% down from its 52 week high and 19.51% up from its 52 week low.
What is Pfizer's market capitalisation today?
Pfizer market capitalisation is $0.16T as on .
How to invest in Pfizer Stock (PFE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Pfizer on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pfizer Shares that will get you 0.0532 shares as per Pfizer share price of $28.18 per share as on September 24, 2026 at 8:45 am IST.
What is the minimum amount required to buy Pfizer Stock (PFE) from India?
Indian investors can start investing in Pfizer (PFE) shares with as little as ₹95.74 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.40 in Pfizer stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pfizer share’s latest price of $28.18 as on September 24, 2026 at 8:45 am IST, you will get 0.3549 shares of Pfizer. Learn more about
fractional shares .
What are the returns that Pfizer has given to Indian investors in the last 5 years?
Pfizer stock has given -35.87% share price returns and 29.82% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?